Skip to main content
Log in

Antiviral activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B virus

  • Research Article
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Bifidobacteria are considered one of the most beneficial probiotics and have been widely studied for their effects in preventing and treating specific pathological conditions. The present study explored the antiviral activity of Bifidobacterium adolescentis SPM0212 isolated from healthy Koreans against hepatitis B virus (HBV) and its mechanism of action. To determine the effect of B. adolescentis SPM0212 against HBV, the level of HBV surface antigen (HBsAg) in the culture medium and the levels of viral transcripts in HepG2.2.15 cells were measured by enzyme-linked immunosorbent assay and reverse transcription-quantitative PCR (RT-qPCR), respectively. To clarify the mechanism, we performed RT-qPCR using specific primers for genes encoding Interferon (IFN)-signaling components and IFN-inducible antiviral effectors. The cell extract of B. adolescentis SPM0212 dose-dependently decreased the extracellular HBsAg level by up to 50 %. Its gene expression in HepG2.2.15 cells was also inhibited by 40 %. This extract significantly increased the expression level of myxovirus resistance A, which is an IFN-inducible antiviral effector. Furthermore, the antiviral activity was observed in the fraction of compound(s) with molecular weights under 30 kDa. Thus, the cell extract of B. adolescentis SPM0212 inhibits HBV and its antiviral mechanism is associated with the Mx GTPase pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Andersson, I., L. Bladh, M. Mousavi-Jazi, K.E. Maqnusson, A. Lundkvist, O. Haller, and A. Mirazimi. 2004. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. Journal of Virology 78: 4323–4329.

    Article  PubMed  CAS  Google Scholar 

  • Arase, Y., K. Ikeda, F. Suzuki, Y. Suzuki, S. Saitoh, M. Kobayashi, N. Akuta, T. Somey, T. Hosaka, H. Sezaki, M. Kobayashi, and H. Kumada. 2006. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B. American Journal of Medicine 119: 71.e9-16.

    Article  PubMed  Google Scholar 

  • Buti, M., and R. Esteban. 2005. Drugs in development for hepatitis B. Drugs 65: 1451–1460.

    Article  PubMed  CAS  Google Scholar 

  • Cha, M.K., D.K. Lee, H.M. An, S.W. Lee, S.H. Shin, J.H. Kwon, and K.J. Kim. 2012. Antiviral activity of Bifidobacterium adolescentis SPM 1005-A on human papillomavirus type 16. BMC Medicine 10: 72. doi:10.1186/1741-7015-10-72.

    Article  PubMed  CAS  Google Scholar 

  • Chen, C.H., C.M. Lee, J.H. Wang, H.D. Tung, C.H. Hung, and S.N. Lu. 2004. Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers. European Journal of Gastroenterology and Hepatology 16: 1213–1218.

    Article  PubMed  CAS  Google Scholar 

  • Chieux, V., W. Chehadeh, J. Harvev, O. Haller, P. Wattre, and D. Hober. 2001. Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein. Virology 283: 84–92.

    Article  PubMed  CAS  Google Scholar 

  • Cho, Y.K., and B.C. Song. 2011. New insight for HBV DNA HBsAg quantitation during antiviral therapy in patients with chronic hepatitis B. Korean Journal of Gastroenterology 57: 144–149.

    Article  PubMed  Google Scholar 

  • De Santis, A., G. Famularo, and C. De Simone. 2000. Probiotics for the hemodynamic alterations of patients with liver cirrhosis. American Journal of Gastroenterology 95: 323–324.

    PubMed  Google Scholar 

  • Gill, H.S., and F. Guarner. 2004. Probiotics and human health: a clinical perspective. Postgraduate Medical Journal 80: 516–526.

    Article  PubMed  CAS  Google Scholar 

  • Gordien, E., O. Rosmorduc, C. Peltekian, F. Garreau, C. Brechot, and D. Kremsdorf. 2001. Inhinbition of hepatitis B virus replication by the interferon-inducible MxA protein. Journal of Virology 75: 2684–2691.

    Article  PubMed  CAS  Google Scholar 

  • Han, S.H., K.H. Cho, C.K. Lee, Y.C. Song, S.H. Park, N.J. Ha, and K.J. Kim. 2005a. Enhancement of antigen presentation capability of dendritic cells and activation of macrophages by the components of Bifidobacterium pseudocatenulatum SPM1204. Journal of Applied Pharmacology 13: 174–180.

    CAS  Google Scholar 

  • Han, S.Y., C.S. Huh, Y.T. Ahn, K.S. Lim, Y.J. Baek, and D.H. Kim. 2005b. Hepatoprotective effect of lactic acid bacteria. Journal of Microbiology and Biotechnology 15: 887–890.

    CAS  Google Scholar 

  • Iloeje, U.H., H.I. Yang, C.L. Jen, J. Su, L.Y. Wang, S.L. You, and C.J. Chen. 2007. Risk and predictors of mortality associated with chronic hepatitis B infection. Clinical Gastroenterology and Hepatology 5: 921–931.

    Article  PubMed  Google Scholar 

  • Im, S.J., and Y.C. Sung. 2006. Action mechanism in immunopathogenesis and clearance of HBV. Korean Journal of Gastroenterology 12: 154–162.

    Google Scholar 

  • Jansen, R.W., L.C. Johnson, and D.R. Averett. 1993. High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay. Antimicrobial Agents and Chemotherapy 37: 441–447.

    Article  PubMed  CAS  Google Scholar 

  • Jia, F., Y.Z. Zhang, and C.M. Liu. 2007. Stable inhibition of hepatitis B virus expression and replication in HeptG2.2.15 cells by RNA interference based on retrovirus delivery. Journal of Biotechnology 128: 32–40.

    Article  PubMed  CAS  Google Scholar 

  • Kao, J.H., and D.S. Chen. 2002. Global control of hepatitis B virus infection. Lancet Infectious Diseases 2: 395–403.

    Article  PubMed  Google Scholar 

  • Kim, B.K., S.Y. Kwon, C.H. Lee, W.H. Choe, H.M. Choi, and H.W. Koo. 2009. Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea. Korean Journal of Gastroenterology 15: 25–41.

    Google Scholar 

  • Korba, B.E., and G. Milman. 1991. A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Research 15: 217–228.

    Article  PubMed  CAS  Google Scholar 

  • Kruining, J., R.A. Heijtink, and S.W. Schalm. 1995. Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment. Journal of Hepatology 22: 263–267.

    Article  PubMed  CAS  Google Scholar 

  • Lavanchy, D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis 11: 97–107.

    Article  PubMed  CAS  Google Scholar 

  • Lee, D.K., S. Jang, E.H. Baek, M.J. Kim, K.S. Lee, H.S. Shin, M.J. Chung, J.E. Kim, and K.O. Lee. 2009a. Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lipids in Health and Disease 8: 21. doi:10.1186/1476-511X-8-21.

    Article  PubMed  Google Scholar 

  • Lee, Y.H., L.J. Kang, and S.G. Lee. 2009b. Nelumbo nucifera leaves extract reduced the production of hepatitis B surface antigen on HepG2.2.15. Korean Journal of Medicinal Crop Science 17: 133–138.

    CAS  Google Scholar 

  • Lee, D.K., S. Jang, M.J. Kim, J.H. Kim, M.J. Chung, K.J. Kim, and N.J. Ha. 2008. Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines. BMC Cancer 8: 310. doi:10.1186/1471-2407-8-310.

    Article  Google Scholar 

  • Lee, D.K., S.Y. Park, S. Jang, E.H. Baek, M.J. Kim, S.M. Huh, K.S. Choi, M.J. Chung, J.E. Kim, K.O. Lee, and N.J. Ha. 2011. The combination of mixed lactic acid bacteria and dietary fiber lowers serum cholesterol levels and fecal harmful enzyme activities in rats. Archives of Pharmacal Research 34: 23–29.

    Article  PubMed  CAS  Google Scholar 

  • Lin, Y.L., M.S. Shiao, C. Mettling, and C.K. Chou. 2003. Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion. Virology 314: 253–260.

    Article  PubMed  CAS  Google Scholar 

  • Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real time quantitative PCR and the 2−ΔΔCT method. Methods 25: 402–408.

    Article  PubMed  CAS  Google Scholar 

  • Miettinen, M., J. Vuopio-Varkila, and K. Varkila. 1996. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infection and Immunity 64: 5403–5405.

    PubMed  CAS  Google Scholar 

  • Nosova, T., H. Jousimies-Somer, K. Jokelainen, R. Hein, and M. Salaspuro. 2000. Acetaldehyde production and metabolism by human indigenous and probiotic Lactobacillus and Bifidobacterium strains. Alcohol and Alcoholism 35: 561–568.

    Article  PubMed  CAS  Google Scholar 

  • Parvez, S., K.A. Malik, S. Ah Kang, and H.Y. Kim. 2006. Probiotics and their fermented food products are beneficial for health. Journal of Applied Microbiology 100: 1171–1185.

    Article  PubMed  CAS  Google Scholar 

  • Perrillo, R.P. 2005. Current treatment of chronic hepatitis B: benefits and limitations. Seminars in Liver Disease 25: 20–28.

    Article  PubMed  CAS  Google Scholar 

  • Sadler, A.J., and B.R. Williams. 2008. Interferon-inducible antiviral effectors. Nature Reviews Immunology 8: 559–568.

    Article  PubMed  CAS  Google Scholar 

  • Sells, M.A., M.L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proceedings of the National Academy of Sciences of the United States of America 84: 1005–1009.

    Article  PubMed  CAS  Google Scholar 

  • Shin, H.S., S.Y. Park, D.K. Lee, S.A. Kim, H.M. An, J.R. Kim, M.J. Kim, M.G. Cha, S.W. Lee, K.J. Kim, K.O. Lee, and N.J. Ha. 2010. Hypocholesterolemic effect of sonication-killed Bifidobacterium longum isolated from healthy adult Koreans in high cholesterol fed rats. Archives of Pharmacal Research 33: 1425–1431.

    Article  PubMed  CAS  Google Scholar 

  • Solga, S.F. 2003. Probiotics can treat hepatic encephalopathy. Medical Hypotheses 61: 307–313.

    Article  PubMed  CAS  Google Scholar 

  • Strober, W. (2001) Trypan blue exclusion test of cell viability. Current Protocols in Immunology, Appendix 3, Appendix 3B doi:10.1002/0471142735.ima03bs21.

  • Su, T.H., C.S. Hsu, C.L. Chen, C.H. Liu, Y.W. Huang, T.C. Tseng, C.J. Liu, P.J. Chen, M.Y. Lai, D.S. Chen, and J.H. Kao. 2010. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antiviral Therapy 15: 1133–1139.

    Article  PubMed  CAS  Google Scholar 

  • Wang, G.F., L.P. Shi, Y.D. Ren, Q.F. Liu, H.F. Liu, R.J. Zhang, Z. Li, F.H. Zhu, P.L. He, W. Tang, P.Z. Tao, C. Li, W.M. Zhao, and J.P. Zuo. 2009. Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. Antiviral Research 83: 186–190.

    Article  PubMed  CAS  Google Scholar 

  • Yuen, M.F., D.K. Wong, E. Sablon, E. Tse, I.O. Ng, H.J. Yuan, C.W. Siu, T.J. Sander, E.J. Bourne, J.G. Hall, L.D. Condreay, and C.L. Lai. 2004. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological and clinical aspects. Hepatology 39: 1694–1701.

    Article  PubMed  Google Scholar 

  • Zhao, R., T.Z. Wang, D. Kong, L. Zhang, H.X. Meng, Y. Jiang, Y.Q. Wu, Z.X. Yu, and X.M. Jin. 2011. Hepatoma cell line HepG2.2.15 demonstrates distinct biological features compared with parental HepG2. World Journal of Gastroenterology 17: 1152–1159.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Professor Yun Gyu Park for providing the HepG2.2.15 cell lines and to Sahmyook University for the financial support. This work was supported by Business for Cooperative R&D between Industry, Academy, and Research Institute funded by the Korea Small and Medium Business Administration (Grants No. 000449270111).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nam Joo Ha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, D.K., Kang, J.Y., Shin, H.S. et al. Antiviral activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B virus. Arch. Pharm. Res. 36, 1525–1532 (2013). https://doi.org/10.1007/s12272-013-0141-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-013-0141-3

Keywords

Navigation